ZBH
US EQUITY
Health Care
Health Care Equipment
CIK: 1136869
Zimmer Biomet (ZBH) Quant Factor Diagnostic & Fair Value Model
Zimmer Biomet (Ticker: ZBH) is listed in the Health Care sector (Health Care Equipment). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$98.56
-0.25%
Latest Close (2026-10-23)
Market Cap: $18.31B
P/E Ratio: 23.9
Momentum Strength
3M / 12M
+7.05%
1M: +9.89%
12M: -5.21%
Quality (ROE)
Point-in-Time
+6.28%
Trailing Return on Equity
Technical Trend
RSI 14
70.9
SMA50: $95.16
SMA200: $91.50
Valuation Multiplier
Trailing
23.9
Moderate Valuation Corridor (15x - 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Moderate Valuation Corridor (15x - 30x P/E)
ZBH trades within a typical sector multiple band (23.9x P/E), broadly aligned with trailing earnings.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 6/9 (Moderate Financial Health)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1136869 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-08-05 | $2.18B | $198.30M | $807.20M | $1.03 |
| 10-Q | 2025-12-31 | 2026-08-05 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-08-05 | $2.08B | $152.80M | $761.00M | $0.77 |
| 10-Q | 2026-03-31 | 2026-05-01 | $2.09B | $238.10M | $359.40M | $1.22 |
| 10-Q | 2025-03-31 | 2026-05-01 | $1.91B | $182.00M | $382.80M | $0.91 |
| 10-K | 2025-12-31 | 2026-02-20 | $8.23B | $705.10M | $1.70B | $3.55 |
| 10-K | 2024-12-31 | 2026-02-20 | $7.68B | $903.80M | $1.50B | $4.43 |
| 10-K | 2023-12-31 | 2026-02-20 | $7.39B | $1.02B | $1.58B | $4.88 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Zimmer Biomet (ZBH) valuation multiples, momentum factors, and point-in-time filing conventions.
How should ZBH's current valuation multiple be interpreted? ↓
ZBH trades at a trailing P/E of 23.9x within the Health Care sector (moderate valuation corridor (15x - 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are ZBH's key momentum and technical factor indicators? ↓
As of the latest close, ZBH shows a 1-month return of +9.89%, 3-month return of +7.05%, and 12-month return of -5.21%, with a 14-day RSI of 70.9. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for ZBH? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can ZBH be incorporated into systematic factor models? ↓
ZBH can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.